Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention

Cardiovascular Revascularization Medicine

Volumn 10, Issue 3, 2009, Pages 144-150

  Delhaye, Cédric ^a,b   Sudre, Arnaud ^a   Lemesle, Gilles ^a   Maréchaux, Sylvestre ^a,b   Broucqsault, Damien ^a   Hennache, Bernadette ^a,b   Bauters, Christophe ^a,b   Lablanche, Jean Marc ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

Author keywords

C Reactive protein; Prognosis; Restenosis; Stent; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ANGIOGRAPHY; ARTICLE; BARE METAL STENT; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; PATIENT INFORMATION; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; SCREENING; SENSITIVITY AND SPECIFICITY; SMOKING; STENT THROMBOSIS;

EID: 67649865356     PISSN: 15538389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carrev.2009.01.005     Document Type: Article

References (27)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
2. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-Reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
3. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 (1997) 973-979
4. Haverkate F., Thompson S.G., Pyke S.D., Gallimore J.R., and Pepys M.B. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 349 (1997) 462-466
5. Liuzzo G., Biasucci L.M., Gallimore J.R., Grillo R.L., Rebuzzi A.G., Pepys M.B., and Maseri A. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 331 (1994) 417-424
6. Ridker P.M., Rifai N., Pfeffer M.A., Sacks F.M., Moye L.A., Goldman S., Flaker G.C., and Braunwald E. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation 98 (1998) 839-844
7. Lamblin N., Mouquet F., Hennache B., Dagorn J., Susen S., Bauters C., and de Groote P. High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure. Eur Heart J 26 (2005) 2245-2250
8. Buffon A., Liuzzo G., Biasucci L.M., Pasqualetti P., Ramazzotti V., Rebuzzi A.G., Crea F., and Maseri A. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 34 (1999) 1512-1521
9. de Winter R.J., Heyde G.S., Koch K.T., Fischer J., van Straalen J.P., Bax M., Schotborgh C.E., Mulder K.J., Sanders G.T., Piek J.J., and Tijssen J.G. The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty. Eur Heart J 23 (2002) 960-966
10. Horne B.D., Muhlestein J.B., Strobel G.G., Carlquist J.F., Bair T.L., and Anderson J.L. Greater pathogen burden but not elevated C-reactive protein increases the risk of clinical restenosis after percutaneous coronary intervention. Am Heart J 144 (2002) 491-500
11. Zhou YF, Csako G, Grayston JT, Wang SP, Yu ZX, Shou M, Leon M, Epstein SE: Lack of association of restenosis following coronary angioplasty with elevated C-reactive protein levels or seropositivity to Chlamydia pneumoniae. Am J Cardiol 1999;84:595-598, A598.
12. Dibra A., Mehilli J., Braun S., Hadamitzky M., Baum H., Dirschinger J., Schuhlen H., Schomig A., and Kastrati A. Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting. Am J Med 114 (2003) 715-722
13. de Winter R.J., Koch K.T., van Straalen J.P., Heyde G., Bax M., Schotborgh C.E., Mulder K.J., Sanders G.T., Fischer J., Tijssen J.G., and Piek J.J. C-Reactive protein and coronary events following percutaneous coronary angioplasty. Am J Med 115 (2003) 85-90
14. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (2002) S1-S266
15. Bassand J.P., Hamm C.W., Ardissino D., Boersma E., Budaj A., Fernandez-Aviles F., Fox K.A., Hasdai D., Ohman E.M., Wallentin L., Wijns W., Vahanian A., Camm J., De Caterina R., Dean V., Dickstein K., Filippatos G., Kristensen S.D., Widimsky P., McGregor K., Sechtem U., Tendera M., Hellemans I., Gomez J.L., Silber S., Funck-Brentano C., Kristensen S.D., Andreotti F., Benzer W., Bertrand M., Betriu A., De Caterina R., DeSutter J., Falk V., Ortiz A.F., Gitt A., Hasin Y., Huber K., Kornowski R., Lopez-Sendon J., Morais J., Nordrehaug J.E., Silber S., Steg P.G., Thygesen K., Tubaro M., Turpie A.G., Verheugt F., and Windecker S. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J 28 (2007) 1598-1660
16. Van Belle E., Perie M., Braune D., Chmait A., Meurice T., Abolmaali K., McFadden E.P., Bauters C., Lablanche J.M., and Bertrand M.E. Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. J Am Coll Cardiol 40 (2002) 410-417
17. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.A., Steg P.G., Morel M.A., Mauri L., Vranckx P., McFadden E., Lansky A., Hamon M., Krucoff M.W., and Serruys P.W. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
18. Ford E.S., Giles W.H., Myers G.L., Rifai N., Ridker P.M., and Mannino D.M. C-Reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999-2000. Clin Chem 49 (2003) 1353-1357
19. Festa A., D'Agostino Jr. R., Howard G., Mykkanen L., Tracy R.P., and Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 (2000) 42-47
20. Das U.N. Is obesity an inflammatory condition?. Nutrition 17 (2001) 953-966
21. Casl M.T., Surina B., Glojnaric-Spasic I., Pape E., Jagarinec N., and Kranjcevic S. Serum amyloid A protein in patients with acute myocardial infarction. Ann Clin Biochem 32 Pt 2 (1995) 196-200
22. Balk E.M., Lau J., Goudas L.C., Jordan H.S., Kupelnick B., Kim L.U., and Karas R.H. Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review. Ann Intern Med 139 (2003) 670-682
23. Ridker P.M., Cannon C.P., Morrow D., Rifai N., Rose L.M., McCabe C.H., Pfeffer M.A., and Braunwald E. C-Reactive protein levels and outcomes after statin therapy. N Engl J Med 352 (2005) 20-28
24. Ridker P.M., Glynn R.J., and Hennekens C.H. C-Reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 97 (1998) 2007-2011
25. Walter D.H., Fichtlscherer S., Sellwig M., Auch-Schwelk W., Schachinger V., and Zeiher A.M. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation. J Am Coll Cardiol 37 (2001) 839-846
26. Cutlip D.E., Baim D.S., Ho K.K., Popma J.J., Lansky A.J., Cohen D.J., Carrozza J.P., Chauhan M.S., Rodriguez O., and Kuntz R.E. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 103 (2001) 1967-1971
27. Kereiakes D.J., Choo J.K., Young J.J., and Broderick T.M. Thrombosis and drug-eluting stents: a critical appraisal. Rev Cardiovasc Med 5 (2004) 9-15